Cell-SELEX: In vitro selection of synthetic small specific ligands

Methods in Molecular Biology

Volumn 1296, Issue , 2015, Pages 213-224

  Dickinson, Helena ^a   Lukasser, Melanie ^a   Mayer, Günter ^a   Hüttenhofer, Alexander ^a  

^a NONE

Author keywords

Amplification; Aptamers; SELEX (systematic evolution of ligands by exponential enrichment); Specific binding interaction

Indexed keywords

APTAMER; BUFFER; DNA; NUCLEIC ACID; RNA; LIGAND; OLIGONUCLEOTIDE;

ARTICLE; BINDING ASSAY; COMBINATORIAL CHEMISTRY; DENATURATION; IN VITRO BINDING ASSAY; IN VITRO SELECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SANGER SEQUENCING; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT; IN VITRO STUDY; METABOLISM; NUCLEIC ACID AMPLIFICATION; PROCEDURES;

APTAMERS, NUCLEOTIDE; IN VITRO TECHNIQUES; LIGANDS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OLIGONUCLEOTIDES; SELEX APTAMER TECHNIQUE;

EID: 84925300170     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2547-6_20     Document Type: Article

References (31)

1. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505-510
2. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818-822
3. Patel DJ (1997) Structural analysis of nucleic acid aptamers. Curr Opin Chem Biol 1:32-46
4. Hermann T, Patel DJ (2000) Adaptive recognition by nucleic acid aptamers. Science 287:820-825
5. Patel DJ, Suri AK (2000) Structure, recognition and discrimination in RNA aptamer complexes with cofactors, amino acids, drugs and aminoglycoside antibiotics. J Biotechnol 74:39-60
6. Schneider DJ, Feigon J, Hostomsky Z et al (1995) High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry 34:9599-9610
7. Mosing RK, Mendonsa SD, Bowser MT (2005) Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. Anal Chem 77:6107-6112
8. Chen F, Hu Y, Li D et al (2009) CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2. PLoS One 4:e8142
9. Kawakami J, Imanaka H, Yokota Y et al (2000) In vitro selection of aptamers that act with Zn2+. J Inorg Biochem 82:197-206
10. Mann D, Reinemann C, Stoltenburg R et al (2005) In vitro selection of DNA aptamers binding ethanolamine. Biochem Biophys Res Commun 338:1928-1934
11. Lauhon CT, Szostak JW (1995) RNA aptamers that bind flavin and nicotinamide redox cofactors. J Am Chem Soc 117:1246-1257
12. Holland CA, Henry AT, Whinna HC et al (2000) Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin. FEBS Lett 484:87-91
13. Bruno JG, Carrillo MP, Phillips T et al (2008) Competitive FRET-aptamer-based detection of methylphosphonic acid, a common nerve agent metabolite. J Fluoresc 18:867-876
14. Ruckman J, Green LS, Beeson J et al (1998) 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem 273:20556-20567
15. White R, Rusconi C, Scardino E et al (2001) Generation of species cross-reactive aptamers using "toggle" SELEX. Mol Ther 4: 567-573
16. Savla R, Taratula O, Garbuzenko O et al (2011) Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. J Control Release 153:16-22
17. Tang Z, Parekh P, Turner P et al (2009) Generating aptamers for recognition of virusinfected cells. Clin Chem 55:813-822
18. Hamula CL, Le XC, Li XF (2011) DNA aptamers binding to multiple prevalent M-types of Streptococcus pyogenes. Anal Chem 83:3640-3647
19. Kolesnikova O, Kazakova H, Comte C et al (2010) Selection of RNA aptamers imported into yeast and human mitochondria. RNA 16:926-941
20. Stoltenburg R, Reinemann C, Strehlitz B (2005) FluMag-SELEX as an advantageous method for DNA aptamer selection. Anal Bioanal Chem 383:83-91
21. Bianchini M, Radrizzani M, Brocardo MG et al (2001) Specific oligobodies against ERK-2 that recognize both the native and the denatured state of the protein. J Immunol Methods 252:191-197
22. Fitzwater T, Polisky B (1996) A SELEX primer. Methods Enzymol 267:275-301
23. Schutze T, Wilhelm B, Greiner N et al (2011) Probing the SELEX process with nextgeneration sequencing. PLoS One 6:e29604
24. Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406-3415
25. Famulok M, Hartig JS, Mayer G (2007) Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. Chem Rev 107:3715-3743
26. Tucker CE, Chen LS, Judkins MB et al (1999) Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide- aptamer (NX1838) in rhesus monkeys. J Chromatogr B Biomed Sci Appl 732:203-212
27. Ng EW, Shima DT, Calias P et al (2006) Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov 5:123-132
28. Higgins DG, Thompson JD, Gibson TJ (1996) Using CLUSTAL for multiple sequence alignments. Methods Enzymol 266:383-402
29. Larkin MA, Blackshields G, Brown NP et al (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948
30. Schneider TD, Stephens RM (1990) Sequence logos: a new way to display consensus sequences. Nucleic Acids Res 18:6097-6100
31. Crooks GE, Hon G, Chandonia JM et al (2004) WebLogo: a sequence logo generator. Genome Res 14:1188-1190